William Harwin
Medical Oncology · Fort Myers, FLNPI 1164413589
Payments from drug & device makers
Across 433 payments — averaging $6358.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Seagen Inc.$1.8M
- Pfizer$919K
- Daiichi Sankyo Inc.$26K
- Sanofi$9K
- Tesaro, Inc.$7K
- AstraZeneca$6K
- plus $13K from 43 others
What the payments were for
- Consulting fees$23,59639%
- Speaking & faculty fees$25,54842%
- Travel & lodging$5,3459%
- Food & beverage$6,01510%
- Education$670%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,753,226 in reported general payments places this provider in the 90th percentile of 507 medical oncology providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Letrozole | 14 | $400 |
Paid to pharmacies, not to this prescriber.
Other medical oncology in Fort Myers
- Lowell HartFort Myers$10.1M
- James ReevesFort Myers$7.1M
- Syed ZafarFort Myers$4M
- Raymond EsperFort Myers$3.2M
- Zeynep ErogluTampa$30.9M
- Manish PatelSarasota$29.7M
- Jad ChahoudTampa$21.8M
- Maen HusseinTavares$18.4M
- Patrick HwuTampa$18M
- Gail WrightHudson$13.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.